Amgen provides our medicines at no cost to qualifying patients in the United States who could otherwise not afford treatment through two foundations.

The Safety Net Foundation is a nonprofit foundation supported by Amgen that provides qualifying, uninsured patients with access to Aranesp® (darbepoetin alfa), EPOGEN® (Epoetin alfa), Neulasta® (pegfilgrastim), NEUPOGEN® (Filgrastim), Nplate® (romiplostim), Sensipar® (cinacalcet), Vectibix® (panitumumab) at no cost.

The ENcourage Foundation® is a nonprofit foundation supported by Amgen and Wyeth that helps make ENBREL® (etanercept) available to qualifying patients. To date, the ENcourage Foundation® has helped more than 24,000 qualifying patients receive treatment with ENBREL at no cost.